Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Azura Ophthalmics Ltd.

News headline image
Azura Ophthalmics Corporate Update: AZR-MD-001 NDA Submission Expected in 2H 2026
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Announces Enrollment of First Patient in Phase 3 Clinical Trial for AZR-MD-001 in Patients with Meibomian Gland Dysfunction (MGD)
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics to Present New Data Supporting the Potential of AZR-MD-001 to be the First Ophthalmic Keratolytic for Ocular Surface Diseases
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics to Present New Data on AZR-MD-001 in Meibomian Gland Dysfunction at American Society of Cataract and Refractive Surgery and Association for Research in Vision and Ophthalmology Annual Meetings
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Announces Participation at the 2023 SVB Securities Global Biopharma Conference
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Announces Participation at Upcoming Investor Conferences
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Expands Broad Intellectual Property Portfolio to 12 U.S. and European Patents
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Provides Update on AZR-MD-001 Phase 2 Clinical Program Targeting Meibomian Gland Dysfunction
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Announces Formation of Scientific Advisory Board (SAB)
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Secures Grant to Evaluate AZR-MD-001 for Improved Vision Quality Related to Contact Lens Discomfort
From Azura Ophthalmics Ltd.
Via Business Wire
News headline image
Azura Ophthalmics Appoints Biopharma Industry Veteran Steven Altschuler, M.D. as Chair of the Board
From Azura Ophthalmics Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.